Related Experiment Videos
Molecular genetics of antithrombin deficiency
1Department of Haematology, Charing Cross and Westminister Medical School, Hammersmith, London, UK.
Blood Reviews
|June 1, 1996
Summary
Antithrombin, a key protein regulating blood clotting, has well-understood structures and functions. Research clarifies genetic causes and clinical impacts of antithrombin deficiency, a risk factor for venous thromboembolism.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- Antithrombin is a crucial inhibitor of thrombin and other blood coagulation proteinases.
- It possesses two main functional domains: a heparin-binding site and a reactive center for proteinase inactivation.
- Antithrombin deficiency elevates the risk of venous thromboembolism.
Purpose of the Study:
- To review recent advancements in understanding antithrombin's structure and function.
- To explore the genetic basis of inherited antithrombin deficiency.
- To correlate genetic defects with clinical consequences.
Main Methods:
- X-ray crystallography to elucidate protein structure.
- Genetic analysis to identify mutations causing deficiency.
- Functional assays to assess protein activity and interactions.
Main Results:
- Structural models explain heparin interaction and reactive loop function.
- The antithrombin gene's organization is defined.
- Mutations identified cause Type I (reduced levels) and Type II (altered function) deficiencies, including pleiotropic effects.
Conclusions:
- Significant progress has been made in understanding antithrombin structure-function relationships.
- Genetic defects in antithrombin lead to deficiency with varying clinical outcomes.
- Knowledge of antithrombin genetics and structure aids in managing thromboembolic risk.